Laboratory for Lipid Medicine and Technology (LLMT), Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA; Institute of Biochemistry and Molecular Biology, Guangdong Medical University, Zhanjiang, Guangdong 524023, China.
Laboratory for Lipid Medicine and Technology (LLMT), Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
Biochim Biophys Acta Gen Subj. 2017 Mar;1861(3):577-584. doi: 10.1016/j.bbagen.2016.12.018. Epub 2016 Dec 21.
Exposure to fine particulate matter, such as through air pollution, has been linked to the increased incidence of chronic diseases. However, few measures have been taken to reduce the health risks associated with fine particle exposure. The identification of safe and effective methods to protect against fine particle exposure-related damage is urgently needed.
We used synthetic, non-toxic, fluorescent fine particles to investigate the physical distribution of inhaled fine particles and their effects on pulmonary and systemic inflammation in mice. Tissue levels of omega-3 fatty acids were elevated via dietary supplementation or the fat-1 transgenic mouse model. Markers of pulmonary and systemic inflammation were assessed.
We discovered that fine particulate matter not only accumulates in the lungs but can also penetrate the pulmonary barrier and travel into other organs, including the brain, liver, spleen, kidney, and testis. These particles induced both pulmonary and systemic inflammation and increased oxidative stress. We also show that elevating tissue levels of omega-3 fatty acids was effective in reducing fine particle-induced inflammation, whether as a preventive method (prior to exposure) or as an intervention (after exposure).
These results advance our understanding of how fine particles contribute to disease development and suggest that increasing tissue omega-3 levels may be a promising nutritional means for reducing the risk of diseases induced by particle exposure.
Our findings demonstrate that elevating tissue omega-3 levels can prevent and treat fine particle-induced health problems and thereby present an immediate, practical solution for reducing the disease burden of air pollution.
暴露于细颗粒物(例如通过空气污染)与慢性病发病率增加有关。然而,很少采取措施来降低与细颗粒暴露相关的健康风险。迫切需要确定安全有效的方法来防止细颗粒暴露造成的损害。
我们使用合成的、无毒的、荧光细颗粒来研究吸入的细颗粒的物理分布及其对小鼠肺部和全身炎症的影响。通过饮食补充或 fat-1 转基因小鼠模型来提高组织中 ω-3 脂肪酸的水平。评估肺部和全身炎症的标志物。
我们发现细颗粒物不仅在肺部蓄积,而且可以穿透肺屏障并转移到其他器官,包括脑、肝、脾、肾和睾丸。这些颗粒诱导肺部和全身炎症,并增加氧化应激。我们还表明,提高组织中 ω-3 脂肪酸的水平可有效减轻细颗粒诱导的炎症,无论是作为预防措施(暴露前)还是干预措施(暴露后)。
这些结果增进了我们对细颗粒如何导致疾病发展的理解,并表明增加组织 ω-3 水平可能是降低颗粒暴露引起的疾病风险的一种有前途的营养方法。
我们的发现表明,提高组织 ω-3 水平可以预防和治疗细颗粒引起的健康问题,从而为减少空气污染造成的疾病负担提供了一种即时的、实用的解决方案。